Mesial temporal lobe epilepsy (MTLE) associated with hippocampal sclerosis (HS) is the most common focal, drug-resistant epilepsy syndrome. Transsylvian or transcortical selective amygdalohippocampectomy (SAH) and anterior temporal lobectomy (ATL) are the most common surgical approaches. Not all patients become seizure-free after surgery. Seizure freedom rate at long-term follow-up has been observed to be 62-83%. 1 Accurate data on outcome and on predictors of outcome after MTLE-HS surgery would allow comparison of different surgical approaches. Furthermore, the low statistical power of studies without multivariate analysis impedes useful predictions of outcomes. The recent histological classification of HS from the International League Against Epilepsy (ILAE) identified different patterns of sclerosis with severe neuronal loss in both CA1 and CA4 regions (type 1), or with neuronal loss mostly limited to CA1 (type 2) or to CA4 (type 3), as well as another group termed "no HS, gliosis only" without severe neuronal loss. 2 Few reports have related surgical outcomes to these different types of HS. [3] [4] [5] This study aimed first to describe the seizure, cognitive, and psychiatric outcomes of a homogenous population of patients with MTLE-HS after different surgical approaches. Second, we attempted to identify factors associated with seizure relapse or cognitive and psychiatric deterioration, in relation to the distinct surgical approaches and patterns of HS. This work also features a multivariate analysis based on clinical, radiological, electrophysiological, histological, and surgical data from MTLE-HS patients.
Methods

Patients
We retrospectively analyzed postoperative outcomes for all adult patients with MTLE-HS who were treated with surgery at the Piti e-Salpêtri ere Hospital in Paris between November 1990 and December 2015. All patients were followed for at least 12 months.
Drug-resistant patients underwent presurgical evaluations. Surgery was proposed to patients with typical hippocampal seizures, epileptiform activity originating from the temporal lobe, and unilateral hippocampal atrophy with or without a T 2 hyperintense signal. These data were analyzed by a multidisciplinary team to determine whether surgical treatment was indicated and whether an epileptic focus could be clearly localized. If so, strict criteria were used to define a single-stage surgical resection, avoiding intracranial electroencephalographic (EEG) recordings when possible. Intracranial EEG recordings were limited to atypical presentation. It was mainly indicated in magnetic resonance imaging (MRI)-negative patients, in case of discordance between electroclinical data and imaging, in multifocal lesions (HS associated with another lesion), or in suspected bitemporal epilepsy. All cases of MRI-negative patients included in this study had a histopathological diagnosis of HS.
Age, gender, medical history, seizure semiology, electrophysiology from surface EEG and intracranial records when performed, and the surgical approach were collected. Pre-and postoperative (at 12 months) neurological, neuropsychological (S.S.), psychiatric (O.P.) examinations, brain MRI, and postoperative histology were also collected. Cognitive function was tested by examinations to measure intellectual quotient and to assess memory (Wechsler Adult Intelligence Scale IV, 16-item Free and Cued Recall, DMS 48), The GRECO neuropsychological semantic battery, emotion processing (mini-SEA), language (verbal fluency, DO80), and executive function (trail making test, Stroop test, Modified card sorting test, Rey/Taylor figure), and by somatosensory tests. Telephone contacts with patients (B.M.) during follow-up evaluated their satisfaction with surgery and quality of life (Table S1 ). Seizure outcomes were assessed using the Engel and ILAE classifications. Hippocampal samples were examined histologically, and all tissue from operations after 1995 was reclassified according to ILAE definitions 2 by two neuropathologists (F.B. and A.L.C.-G.). Contradictions between classifications were resolved by a third senior neuropathologist (C.D. 
Surgical methodology
Three surgical approaches were used: (1) Spencer's ATL, 6 (2) SAH via transsylvian approach, 7 and (3) SAH via transcortical trans-superior temporal gyrus (STG) approach. 8 ATL was used between 1990 and 2010, transsylvian SAH between 1994 and 2000, and SAH with a transcortical approach after 2000 (Fig. 1) . All surgeries were performed by the same neurosurgeon (S.C.).
The decision to perform an ATL or an SAH was first based on timing, and then on the results of the presurgical evaluation. Before 1994, patients who underwent surgery for MTLE-HS received an ATL, as this was the practice at our center. Between 1994 and 2010, SAH was used for patients with a high risk of postoperative cognitive deterioration. In 2010, the transcortical SAH was definitively adopted as the standard operation for MTLE-HS. Some surgical centers including ours suggest that one advantage of transcortical SAH, in comparison with transsylvian SAH, is to minimize the need to divide vascular adhesions, which is tedious and time-consuming, and which sometimes provokes a degree of cerebral swelling. 9, 10 The trans-STG keyhole SAH is a minimally invasive 8 and safe 9 technique that allows disconnection of the temporal stem (unlike a transmiddle temporal gyrus approach, a trans-inferior temporal gyrus approach, or a subtemporal approach) and resection of temporomesial structures.
Postoperative management
In the postoperative period, antiepileptic drugs were resumed at full dose and the patient was then carefully monitored for seizures. We started antiepileptic drug withdrawal at 1 year after surgery in seizure-free patients. We therefore reported seizure outcome from the first postoperative year.
Statistical analysis
Statistical analysis was performed with SPSS, version 21 (IBM, Armonk, NY, U.S.A.). Kaplan-Meier survival curves investigated the probability that seizure outcome of patients after surgery was maintained in Engel class Ia or I. Potential risk factors for seizure recurrence were examined using the Cox proportional model. Differences between groups were analyzed with the log-rank test for the univariate phase. Variables with p < 0.2 in univariate analyses were included in a multivariate Cox proportional regression model. The level of significance for multivariate analyses was set at p < 0.05. Analyses were reconfigured to investigate association of risk factors with Engel outcomes other than classes Figure 1 . Different surgical approaches used for mesial temporal lobe epilepsy-hippocampal sclerosis resection over the time. The anterior temporal lobectomy consists of an anterior temporal cortical resection followed by removal of the temporal mesial structures. The rationale for the selective amygdalohippocampectomy is to spare cerebral tissue not included in the seizure generator. The transsylvian approach allows temporomesial resection through the Sylvian fissure. The transcortical superior temporal gyrus (STG) approach allows disconnection of the temporal stem and resection of temporomesial structures. Epilepsia ILAE Ia and I. Associations between continuous variables, such as age at epilepsy onset and surgery, duration of epilepsy, seizure frequency, and Engel class I outcomes were evaluated using a univariate logistic regression model.
For cognitive and psychiatric outcomes, we used simultaneous binary logistic regression models to ask how independent variables were linked to outcome. Differences between groups were assessed with the two-tailed Fisher's exact test or chi-square test for categorical variables, and Student t test for continuous variables. Possible outcome predictors with a regression coefficient p < 0.2 in the binary logistic regression analysis were included in a multivariate logistic regression analysis. A probability p < 0.05 was considered statistically significant. These statistical tests included a Bonferroni correction.
Results
Patient demographics, surgery, and histology
We analyzed mesial temporal lobe resections from 389 patients with severe and/or disabling drug-resistant MTLE-HS. Patient characteristics are summarized in Table 1 . Age at surgery was 36.8 AE 10.5 years (range = 15.4-67.9), and the female/male ratio was 1.1. An initial precipitating injury, such as febrile seizure, was identified for 79.6% of patients and occurred at a mean age of 2.1 AE 3.6 years (range = 0.0-33.0). The first spontaneous seizure occurred at 12 AE 9.1 years (range = 0.0-47.4), and the mean seizure frequency just before surgery was 6 AE 5 seizures per month (range = 0.5-100). The mean duration of epilepsy was 24.9 AE 11.4 years (range = 2.1-58.4). Preoperative generalized status epilepticus occurred in 9.2% of the patients. Brain MRI showed a typical pattern of HS in 95% of the patients. Intracranial EEG records were necessary in 43 patients (11.1%) before temporal resection. Thirty-five patients (9%) suffered from a systemic disease in addition to epilepsy, 56.7% were treated with three or more antiepileptic drugs at the time of surgery, and 67.1% were employed.
The surgical approach was ATL for 209 cases (53.7%), trans-STG SAH for 144 cases (37%), and transsylvian SAH for 36 cases (9.3%). Surgery was performed on the left hemisphere in 206 patients (53%) and on the right hemisphere in 183 (47%). We have previously reported in the same population low perioperative morbidity after MTLE-HS surgery. 9 We examined postoperative tissue from 314 of 389 MTLE surgeries. Hippocampal structures were too fragmented to permit HS classification 2 for 24 samples, and HS type could not be defined with certainty for a further 39 samples. The remaining tissue samples were classed as type 1 HS for 189 patients (75.3%), type 2 for 47 patients (18.7%), type 3 for three patients (1.2%), and type no-HS for 12 patients (4.8%). DPs were detected in 2.9% of temporal lobe tissue samples.
Seizure outcomes
Seizure outcome was defined as follow-up at a time point >1 year after surgery in 361 patients. The mean duration of follow-up was 8.7 AE 5.8 years (range = 1.0-25.2 years). Ten patients (2.6%) of the cohort died, on average at (Fig. 2) . Using the ILAE classification, 71.2% of the patients had a class 1 outcome, 9.2% had a class 2 outcome, 15.9% had a class 3 outcome, 2.3% had a class 4 outcome, and 1.5% had a class 5 outcome. Two variables were found to significantly modify the Kaplan-Meier survival curves made to correlate Engel class I outcome with clinical, radiological, histological, and electrophysiological variables (Table 2) : the preoperative occurrence of status epilepticus (log-rank test, p = 0.003; Fig. 3A ) and the need for intracranial EEG records (p = 0.002; Fig. 3C ). For patients with an Engel class Ia outcome, five preoperative variables were significantly discriminative: an associated systemic disease (p = 0.04), a status epilepticus (p = 0.03; Fig. 3B Fig. 3D ). Kaplan-Meier survival curves revealed no significant effect of the three different surgical approaches on seizure outcome (Engel class I, p = 0.94 and Ia, p = 0.74; Fig. 3E,F) . Moreover, we found no difference between patients with type 1 or type 2 HS for patients with Engel class I (p = 0.35) or Ia (p = 0.79) outcomes (Figs. 3G,H and 4C,D) . Equally, there was no influence on seizure outcome of dual morphological pathologies identified on histological examination of hippocampal samples (Engel class I, p = 0.75 and Ia, p = 0.49). We also found that normal mesial temporal lobe defined from MRI (Fig. 4E,F) and the no-HS type (Fig. 4A,B) were not significantly associated with an unfavorable seizure outcome. At 5-and 10-year follow-up, neither age at epilepsy onset (t test, p = 0.99 and p = 0.29, respectively), age at surgery Table 2 ). For Engel class II-IV, predictors of an unfavorable seizure outcome were a preoperative status epilepticus (20.0%, 12 of 60, p = 0.02, OR = 2.3, 95% CI = 1.1-4.6) and intracranial EEG records (19.5%, 16 of 82, p = 0.03, OR 2.1, 95% CI = 1.1-4.1).
Cognitive outcomes
Preoperative tests revealed normal cognitive performance in only 8.8% (29 of 328) of patients. Deficits in verbal memory were found in 37.8% (124 of 328) of patients, deficits in nonverbal memory in 19.5% (64 of 328), and deficits in global memory in 33.8% (111 of 328).
Postoperative tests revealed a decreased overall cognitive performance in 26.6% (80 of 301) of patients and an improvement in 18.3% (55 of 301). Verbal and nonverbal memory scores decreased after surgery for 26.5% and 8.4% of patients, respectively (Fig. S1) . Table 3 shows predictors of a postoperative cognitive decline. Risks of cognitive and/ or verbal memory impairment were 3.12 (95% CI = 1.27-7.70) and 4.15 (95% CI = 1.84-9.33), greater in patients with ATL than in those with SAH.
Psychiatric outcomes
Preoperative tests identified psychiatric disorders in 29.3% (94 of 321) of patients. The most frequent disorder was depression, which was seen in 79.8% (75 of 94) of patients. Bipolar, psychotic, and personality disorders were also observed.
In the weeks or months after surgery 38.9% (138 of 355) of patients reported depression. At longer-term follow-up examinations, psychiatric status was improved for 20.2% (66 of 327) of patients and was unchanged for 54.4% (178 of 327). Early or delayed postsurgical psychiatric status worsened for 25.4% (83 of 327) of patients. Table 3 summarizes predictors of a degraded postoperative psychiatric status.
Relationships between seizure, cognitive, and psychiatric outcomes Figure 5 summarizes the relationships between seizure, cognitive, and psychiatric outcomes across all patients. Whereas poor seizure outcome was not significantly associated with poor cognitive or psychiatric outcome, cognitive impairment was significantly linked to poor psychiatric outcome (p = 0.007, OR = 3.8, 95% CI = 1.4-9.8).
Quality of life outcome and patients' satisfaction with surgery
Quality of life at the latest follow-up was reported as improved by 80.9% (246 of 304) of patients and unchanged by 17.4% (53 of 304) of patients. Five patients (1.6%) reported a decreased quality of life. They experienced either a persistent neurological deficit (n = 2) or a poor seizure outcome (Engel class IV, n = 3).
A total of 22.3% of patients (73 of 328) found new employment after their surgery, whereas 1.2% (4 of 328) stopped working after surgery. Nearly all patients (96.7%, 294 of 304) were pleased with their decision to undertake surgery. A majority (76.3%) considered their surgery not to be associated with elevated risk. Ten patients expressed regrets after surgery. Seizures persisted for six of them, three reported disabling visual field defects, two had memory deficits, and one reported a motor deficit.
Discussion
Seizure outcomes
Our 25-year study on a homogenous population of 389 MTLE-HS patients undergoing surgery showed 83.7% patients to be Engel class I at their latest follow-up evaluation. In other studies (Table S2) , Engel class I values of 34-93% are described for MTLE patients in the 5th year after surgery. 4, [11] [12] [13] [14] This wide variability may partly reflect Preoperative status epilepticus (A, B) or intracranial electroencephalographic (EEG) records (C, D) were both associated with a worse long-term seizure outcome. Neither the surgical approach (E, F) nor the hippocampal sclerosis (HS) type (G, H) was significantly associated with long-term seizure outcome. *p < 0.05, **p < 0.01. ATL, anterior temporal lobectomy; SAH, selective amygdalohippocampectomy; STG, superior temporal gyrus. Epilepsia ILAE different styles of postoperative management. Antiepileptic drugs are tapered rapidly at some centers, whereas at others preoperative medication regimes are maintained over longer periods.
The SAH approach is intended to spare cerebral tissue that does not contribute to seizure generation, although the volume of temporal lobe that should be resected is still debated. Although no randomized comparison of SAH and ATL has previously been published, most studies 10, 12, 14, 15 suggest these distinct surgical approaches have similar seizure outcomes after MTLE-HS surgery. One meta-analysis reported a better outcome for ATL rather than the SAH technique. 16 Here, we found no difference in seizure outcome after ATL, transsylvian SAH, or transcortical SAH.
We found no correlation between postoperative outcome and the ILAE HS pattern, 2 or the presence of a DP. Conversely, two studies 3, 5 concluded that HS type 1 patients had better seizure outcomes that those with HS type 2, and one 4 found the reverse association. A preoperative episode of status epilepticus (9.2% of patients) and need for intracranial EEG recording (11.1%) were linked to less favorable seizure outcomes after surgery. Epileptogenic networks in these patients may have been more widespread or more complex. Links between history of status epilepticus and unfavorable outcome may result either from the underlying etiology in a subgroup of epileptic patients more prone to such events, or from cortical lesions induced by severe status distant from the hippocampal primary epileptogenic focus. Previously identified predictors of poor surgical outcome include a higher seizure frequency 17 ; secondary generalized tonic-clonic seizures 18 ; the temporal plus epilepsy syndrome, where epileptogenic networks seem to be spatially more extended 18 ; or a longer duration of epilepsy. 19 We did not find a link between age at surgery and poor seizure outcomes, as others did. 20 Seizure outcomes after surgery in MTLE patients with no sclerosis visible on MRI were reported to be worse than those of patients with MRI abnormaties. 21 Our univariate analyses showed this feature was a nonsignificant predictor of poor outcome.
Cognitive outcomes
Cognitive performance decreased in 26.6% of patients after surgery. As previously reported, 22 verbal memory may worsen after dominant hemisphere resection (in 26.5% of these patients and 25-51% in the literature). Nonverbal memory decreased postoperatively in fewer patients (8.4%), at a rate similar to previous reports (6-32%). 23 Poor outcomes for seizure control after MTLE-HS surgery were not statistically associated with poor cognitive or psychiatric outcomes (Fig. 5) , suggesting that different networks are involved.
We identified a higher risk of cognitive and/or verbal memory impairment after ATL than after SAH. Some studies have suggested that the SAH approach induces less cognitive deficit than ATL, especially in verbal memory and intellectual quotient (Table S3) . 14, [24] [25] [26] [27] This deficit in verbal memory, especially in naming, can be attributed to the resection of lateral temporal neocortex. 28 Others did not find SAH superior to ATL for cognitive outcome. [29] [30] [31] [32] Memory deficits seem to differ little between transcortical and transsylvian approaches. 33 Multivariate analyses identified three predictors of cognitive deficits: HS type 2, preoperative verbal memory deficit, and high seizure frequency. Patients with left HS type 2 showed better preoperative verbal memory than those with left type 1 or type 3 HS. 3 Impaired memory function after ATL surgery is suggested to be inversely correlated to hippocampal neuronal loss. 34 Our data revealed a higher probability of verbal memory impairment after ATL or surgery of the left hemisphere, as reported previously.
14 Previous predictors of verbal memory impairment include a later age at seizure onset or at surgery, left hemisphere HS, and functional status of the mesial temporal lobe. 23 Intuitively, resection of a structurally intact functional hippocampus should result in a greater deficit. 26 Patients with good memory function and higher intellectual quotient before surgery report lesser postoperative memory decline. 35 Predictors of nonverbal memory worsening in our cohort are an advanced age at surgery and major postoperative complications. Previous work has also identified as risk factors a later age of seizure onset and the functional status of the resected mesial temporal lobe. 36 
Psychiatric outcomes
MTLE-HS syndromes are linked to psychiatric disorders. Depression was present in 38.9% of patients after surgery, as reported previously 37 ; 25.4% reported new and persistent psychiatric complications or an exacerbation of an existing condition. Increased level of paranoia was reported in MTLE-HS patients after ATL. 12 No significant link between surgical approach and either short-or long-term levels of postoperative depression was reported in our study or by others. 14 The strongest predictor of a poor psychiatric outcome after surgery was a psychiatric history before surgery. Our data revealed a novel correlation between a decreased cognitive function and a worsened psychiatric outcome after the operation (Fig. 4) . We did not find evidence to support the suggestion 38 that postsurgical mood improvements were limited to patients with a good or excellent seizure outcome.
Relationships between preoperative psychiatric history and seizure outcome are controversial. Whereas some authors 39 found that a prolonged psychiatric history before MTLE-HS operations with the ATL approach was associated with a poor seizure outcome, others 40 found no correlation between 1-year seizure outcome after ATL surgery for patients with a lifetime history of depression or psychosis. Our data tend to suggest that psychiatric history is not with associated seizure outcome.
Patient self-evaluation
About 80% of patients reported an improved quality of life after surgery. 14, 41 Freedom from seizures was important, but most patients felt their life improved even if they were not seizure-free. This satisfaction was unrelated to Venn diagram of the relationships between patients with poor seizure (Engel class II-IV), cognitive, and psychiatric long-term outcomes. Postoperative cognitive impairment was associated with poor psychiatric outcome. **p < 0.01. Epilepsia ILAE surgical approach 14 and often associated with an improved professional status. 41 Most patients (96.7%) did not regret deciding to undertake epilepsy surgery regardless of whether they were completely seizure-free and regardless of the timing of their latest follow-up. In other studies of satisfaction with MTLE surgery, 41 most patients were positive, with the highest levels of satisfaction among those who were completely seizure-free.
Conclusion
This retrospective study confirms long-term benefits of surgical resections for patients with MTLE-HS. 42 Three distinct surgical approaches provided similar favorable rates of postoperative seizure control. More than 80% of patients were Engel class I at their latest follow-up, but only 57% of patients were Engel class Ia. Resections carried out with the ATL or SAH procedure showed the same seizure outcome. The optimal procedure and extent of temporal lobe resections are still debated. Over the past 25 years, there has been a strong trend to reduce the extent of resections. Improved data from presurgical investigations and understanding of how resections can affect memory function have led surgeons to more selective resections. Our data suggest that the transcortical SAH approach minimizes cognitive deterioration after MTLE-HS surgery. Together with the low morbidity associated with transcortical SAH, these factors tend to favor the use of this approach in MTLE-HS surgery. This conclusion should be confirmed in a randomized comparison of SAH and ATL.
Our multivariate analyses found no significant association between HS type and surgical outcomes. Previous work on this point has led to contradictory conclusions. Future explorations of relations between the type of sclerosis and surgical outcome should be prospective and need to examine the pattern and degree of neuronal loss with greater precision. In conclusion, outcomes from surgery on MTLE-HS patients are often favorable, and can be predicted with reasonable accuracy from preoperative clinical, radiological, and electrophysiological data.
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